pharmaceutical tariffs
Economist Gita Gopinath's Analysis Reveals Trump Tariffs Delivering Negative Results for US Economy
Oct 08, 2025 10:51 am CST
Former IMF Chief Economist Gita Gopinath has conducted a six-month assessment of President Trump's controversial tariff policies, concluding they have primarily functioned as a tax on American businesses and consumers while failing to improve manufacturing or trade balance. Her analysis reveals these protective measures have increased inflation in certain sectors without delivering the promised economic benefits, adding expert validation to growing concerns about the administration's aggressive trade approach.
Trump Jokes About COVID When Health Secretary Kennedy Sneezes During Pfizer Drug Price Announcement
Oct 01, 2025 03:39 pm CST
During a White House briefing on prescription drug costs, President Trump jokingly requested Paxlovid when Health Secretary Robert F Kennedy Jr sneezed behind him. The meeting also featured announcements about a Pfizer tariff exemption and the launch of "TrumpRx," a new government website designed to reduce medication costs for Americans by eliminating middlemen in the pharmaceutical supply chain.
Trump Announces Major Pfizer Deal to Lower US Drug Prices After Humorous COVID Moment in Oval Office
Oct 01, 2025 03:39 pm CST
President Trump unveiled a groundbreaking agreement with Pfizer aimed at reducing prescription drug costs in the US, during a White House briefing that featured a lighthearted moment when Health Secretary Robert F Kennedy Jr sneezed nearby. The deal includes a new "TrumpRx" platform allowing direct consumer purchases from Pfizer, bypassing middlemen, while also granting the company a three-year exemption from recently announced pharmaceutical tariffs.
Trump's 100% Pharmaceutical Tariffs Face EU Resistance Citing Trade Deal Immunity
Sep 26, 2025 08:44 pm CST
President Trump has announced steep new tariffs on pharmaceuticals and other imported goods, with the EU claiming immunity under a previous trade agreement. The measures include a 100% tariff on pharmaceutical products, 25% on heavy trucks, and significant tariffs on furniture and kitchen products. These protectionist policies aim to rebuild US manufacturing but have sparked concerns about inflation and supply chain disruptions among international allies and trading partners.
Trump Announces 100% Tariff on Pharmaceutical Imports Unless Companies Build US Manufacturing Plants
Sep 26, 2025 11:42 am CST
President Donald Trump has announced 100% tariffs on pharmaceutical imports effective October 1, 2025, with exemptions for companies actively constructing manufacturing facilities in the US. The policy could significantly impact India's pharmaceutical sector, which exports over $3.6 billion in products to the US annually. This move follows recent 50% tariffs imposed on India for purchasing Russian oil, as bilateral trade negotiations continue.
Trump's New Import Tariffs: 100% on Pharmaceuticals, 50% on Cabinets, and Impact on U.S. Economy
Sep 26, 2025 08:25 am CST
President Trump has announced significant new tariffs starting October 1, including 100% on pharmaceutical drugs, 50% on kitchen cabinets, 30% on furniture, and 25% on heavy trucks. While aimed at boosting domestic manufacturing and reducing budget deficits, these tariffs may increase inflation and healthcare costs, with limited evidence of manufacturing job creation.